Indegene
 | This lead contains promotional content. (August 2021) |
 | |
| Formerly | Indegene Lifesystems Private Limited (1998–2016) Indegene Private Limited (2016–2022) |
|---|---|
| Company type | Public |
| Industry | Pharmaceutical consultancy[1] |
| Founded | 1998 |
| Founders | Rajesh Nair Manish Gupta Sanjay Parikh Anand Kiran Gaurav Kapoor |
| Headquarters | , India |
Area served | Worldwide |
Key people | Manish Gupta (CEO)[2] |
| Revenue |  ₹2,589 crore (US$310 million) (FY24)[3] |
| ₹584 crore (US$70 million) (FY24)[3] | |
| ₹336 crore (US$40 million) (FY24)[3] | |
| Owners |
|
Number of employees | 5,081 (March 2024)[3] |
| Website | www |
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises.[5][6][7] Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics.[8][9]
History
[edit]Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran.[10] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States.[11] In 2008, Medsn officially became Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States.[7][12]
In 2009, Indegene signed a master service agreement with six pharmaceutical companies.[6][13] The following year, Indegene acquired Canada-based Aptilon, a multichannel marketing firm, for $4 million.[14] The company subsequently acquired Atlanta-based Total Therapeutic Management in 2014.[15]
In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million.[16]
In February 2021, the Carlyle Group and Brighton Park Capital invested $200 million in Indegene.[17] In August 2021, Indegene acquired Medical Marketing Economics (MME), an American market access and pricing strategy company, for $10 million.[18]
Indegene went public in May 2024 with an initial public offering, raising ₹1,842 crore (US$220 million). It listed on the BSE and the NSE.[19]
Operations
[edit]Indegene has offices in India, the United States, the European Union, and Asia-Pacific.[20][12]
In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry.[21]
References
[edit]- ^ "Indegene ends 26% higher on listing day". 13 May 2024.
- ^ "Indegene on the prowl for global acquisitions". The Hindu Businessline. 12 August 2020. Retrieved 8 January 2023.
- ^ a b c d "Fact Sheet – Q4 FY2024" (PDF). Indegene. Retrieved 30 May 2024.
- ^ "PE firms Carlyle, Nadathur Fareast, Brighton Park Capital-backed Indegene IPO to open on May 6". Moneycontrol. Retrieved 28 April 2024.
- ^ Das, Avik (2 September 2015). "Flipkart, Practo CEOs get top rating from staff". The Economic Times. Archived from the original on 8 September 2015. Retrieved 2 October 2015.
- ^ a b Singh, Seema (7 May 2009). "Cutting pharma costs by intelligent marketing". Mint. Retrieved 2 October 2015.
- ^ a b Unnikrishnan, CH (8 November 2006). "Indegene buys US firm". Business Standard. Retrieved 2 October 2015.
- ^ Murayama, Keiichi (19 February 2015). "India's tech muscle has the world's attention". The Nikkei. Retrieved 2 October 2015.
- ^ "Indegene files papers with Sebi; eyes ₹3,200 crore via IPO". mint. 15 December 2022. Retrieved 8 January 2023.
- ^ Amirapu, Deepika (9 March 2012). "Indegene eyes US call centre buy for $10–15 million". The Economic Times. Archived from the original on 19 November 2015. Retrieved 2 October 2015.
- ^ D'Silva, Jeetha (17 September 2005). "Indegene acquires US medical education co". The Economic Times. Archived from the original on 16 October 2015. Retrieved 2 October 2015.
- ^ a b "Indegene acquires MedCases, LLC". NFV Zone. 30 November 2006. Retrieved 2 October 2015.
- ^ "Indegene highlights benefits of patient adherence programs for pharma cos". PharmaBiz. 3 June 2011. Retrieved 2 October 2015.
- ^ Mukherjee, Rupali (7 November 2012). "Indegene to acquire Canada-based company for $4 million". Times of India. Retrieved 2 October 2015.
- ^ Craig, Tara (9 January 2014). "Indegene acquires Total Therapeutic Management". PMLive.com. Retrieved 2 October 2015.
- ^ Balakrishnan, Reghu (3 September 2019). "Healthcare tech firm Indegene acquires DT Associates". The Economic Times. Retrieved 28 April 2024.
- ^ Madhurima, Nandy (3 February 2021). "Indegene to raise $200 mn from Carlyle, Brighton Park". LiveMint. Retrieved 20 August 2021.
- ^ Baruah, Ayushman (30 August 2021). "Indegene acquires US-based Medical Marketing Economics for $10 mn". Mint. Retrieved 28 April 2024.
- ^ Narayanan, KS Badri (6 May 2024). "Indegene IPO opens today in ₹430-452 price band". BusinessLine. Retrieved 6 May 2024.
- ^ Vijay, Nandita (7 November 2012). "Indegene plans next phase of growth through acquisition in US, EU markets". PharmaBiz. Retrieved 2 October 2015.
- ^ "Best companies to work for 2012: Companies that came up trumps across various sectors". The Economic Times. 16 July 2012. Archived from the original on 11 April 2013. Retrieved 2 October 2015.